Health · September 3, 2026 · 7 min read

Testosterone therapy: what's hype and what's evidence

TRT is everywhere. Here is what the data says about who actually benefits, what the real risks are, and why a good protocol is rarely testosterone alone.

Testosterone therapy is one of the most discussed and least carefully read topics in men's health. Much of what circulates online is either marketing for an "optimization" package or reflexive skepticism left over from older, weaker data. The clinical picture is narrower and more useful than either.

What low testosterone actually looks like

Testosterone falls roughly 1% per year from around age 30. For most men that decline stays unremarkable. For others it becomes symptomatic: flat energy and motivation, reduced libido or erectile dysfunction, loss of muscle mass and strength, irritability or brain fog, and in some cases anemia or reduced bone density.

Deficiency is more common than most men assume — reported in roughly 12% to 39% of men from their fifties through their eighties, and about 35% of men over 45, with higher rates alongside obesity or type 2 diabetes.

Diagnosis is not a single number. The American Urological Association threshold is under 300 ng/dL, confirmed on two separate early-morning fasting draws, paired with real symptoms. One low afternoon lab does not diagnose hypogonadism, and a low number without symptoms does not either. Treating a lab value instead of a patient is where most of the hype begins.

What the evidence shows

For over a decade, cardiovascular uncertainty shaped both the FDA labeling and clinical guidelines. The TRAVERSE trial — the largest randomized, placebo-controlled testosterone trial run to date, with 5,426 men aged 45 to 80 who already had cardiovascular disease or high risk, followed for an average of 27 months — changed that picture. Testosterone gel was non-inferior to placebo for major cardiovascular events, with no signal of increased heart attack, stroke, or prostate cancer.

Two findings are worth raising with a prescriber: slightly more atrial fibrillation and slightly more fractures in the testosterone group. Both matter for men with existing rhythm or bone concerns. On the other side, men with prediabetes at baseline showed a notable reduction in progression to type 2 diabetes.

The honest read: for a genuine, properly monitored diagnosis, therapy looks considerably safer than the headlines implied. That is not an argument for casual use in men without deficiency.

It is rarely testosterone alone

hCG. External testosterone suppresses the brain's signal to the testes, which over months can mean testicular atrophy and a sharp drop in fertility. hCG mimics that natural LH signal directly at the testes, keeping them active — the usual tool for men who want to preserve fertility.

Anastrozole. Some testosterone converts to estrogen via aromatase. A healthy amount of estrogen is necessary; too much shows up as water retention, mood changes, or breast tissue changes. Anastrozole blocks that conversion, but it is a fine-tuning tool rather than a default — pushing estrogen too low brings joint pain, low libido, mood changes, and lipid disruption.

Enclomiphene. This raises testosterone without administering testosterone. By blocking the estrogen-driven feedback that tells the brain to slow production, it increases the body's own output — which means sperm production and fertility are preserved rather than suppressed.

Why supervision is the whole point

Every element above depends on accurate diagnosis, real lab follow-up, and dose adjustment over time. Rise Wellness and Longevity protocols include Quest Diagnostics lab panels, prescriptions written by board-certified physicians, direct clinician messaging, and dispensing exclusively through licensed 503A and 503B pharmacies — no gray market, no research-use-only material.

Sources

Adapted for Rise Wellness and Longevity from reporting originally published by Altro Health. Educational content only; not medical advice.

Find your protocol All articles